Enzymotec Ltd. Asset Turnover Ratio (ENZY), as of fourth quarter 2016, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Enzymotec Ltd.  (ENZY)
 

Enzymotec Ltd. Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Enzymotec Ltd.'s asset turnover ratio, the ratio that measures the ability of Enzymotec Ltd.'s assets to generate revenue, sequentially decreased to 0.33 in the fourth quarter (Dec 31 2016), which does not come as a surprise, as the Enzymotec Ltd. continue to experience difficult business climate.

Within sector 16 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2016 compared to the preceding quarter from 0 to 2537.

Asset Turnover Ratio Definition



ENZY Asset Turnover Ratio (Dec 31 2016)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Asset Change 0.58 % -2.02 % -2.02 % -2.02 % 52.98 %
Y / Y Revenue Change -5.35 % - - - 6.98 %
Asset Turnover Ratio (TTM) 0.33 - - - 0.35
ENZY's Total Ranking # 2537 # 0 # 3065 # 0 # 0
Seq. Asset Change -8.1 % 0 % 0 % 9.44 % -10.47 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 291
Overall Market # 2537

Asset Turnover Ratio Statistics
High Average Low
0.34 0.33 0.32
(Dec 31 2015)   (Dec 31 2016)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2016, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2016 Assets at quarter ending Dec 31 2016
Lakeland Industries Inc   0.98 $ 86.183  Millions$ 88.260  Millions
Achari Ventures Holdings Corp I  0.98 $ 791.003  Millions$ 810.747  Millions
Cba Florida Inc   0.97 $ 3.288  Millions$ 3.399  Millions
Biomerica Inc   0.96 $ 5.530  Millions$ 5.735  Millions
Pacific Health Care Organization Inc  0.96 $ 5.688  Millions$ 5.901  Millions
Biocorrx Inc   0.95 $ 0.702  Millions$ 0.741  Millions
Chembio Diagnostics Inc   0.94 $ 17.869  Millions$ 19.030  Millions
Iradimed Corporation  0.94 $ 32.497  Millions$ 34.621  Millions
Optec International, Inc.  0.93 $ 0.025  Millions$ 0.027  Millions
International Stem Cell Corporation  0.93 $ 7.165  Millions$ 7.709  Millions
Harvard Bioscience Inc   0.93 $ 104.521  Millions$ 112.977  Millions
Nrc Health  0.92 $ 109.384  Millions$ 118.699  Millions
Icon Plc  0.91 $ 1,666.487  Millions$ 1,825.843  Millions
Bruker Corporation  0.91 $ 1,611.300  Millions$ 1,766.650  Millions
Community Health Systems Inc   0.91 $ 21,275.000  Millions$ 23,331.750  Millions
Carlisle Companies Incorporated  0.91 $ 3,675.400  Millions$ 4,031.650  Millions
Lemaitre Vascular Inc   0.91 $ 89.151  Millions$ 98.036  Millions
Glaukos Corp  0.91 $ 114.397  Millions$ 126.010  Millions
Abiomed Inc   0.91 $ 414.581  Millions$ 457.276  Millions
3m Company  0.90 $ 30,109.000  Millions$ 33,293.500  Millions
Vycor Medical Inc   0.90 $ 1.453  Millions$ 1.618  Millions
Penumbra Inc  0.90 $ 263.317  Millions$ 293.461  Millions
Coherus Oncology inc   0.90 $ 190.106  Millions$ 212.045  Millions
Cytosorbents Corporation  0.89 $ 9.528  Millions$ 10.694  Millions
Natera Inc   0.89 $ 217.074  Millions$ 245.020  Millions
West Pharmaceutical Services Inc   0.88 $ 1,509.100  Millions$ 1,706.325  Millions
Fonar Corporation  0.88 $ 74.525  Millions$ 84.567  Millions
Prophase Labs Inc   0.88 $ 11.048  Millions$ 12.615  Millions
Cambrex Corp  0.87 $ 490.644  Millions$ 562.001  Millions
Aeon Global Health Corp.  0.87 $ 44.089  Millions$ 50.827  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.